The market for ulcerative colitis
Nat Rev Drug Discov
.
2022 Jan;21(1):15-16.
doi: 10.1038/d41573-021-00194-5.
Authors
Rami Al-Horani
,
Eleonora Spanudakis
,
Bashar Hamad
PMID:
34815547
DOI:
10.1038/d41573-021-00194-5
No abstract available
Publication types
News
MeSH terms
Colitis, Ulcerative / drug therapy*
Drug Industry / methods
Gastrointestinal Agents / therapeutic use*
Humans
Substances
Gastrointestinal Agents
Grants and funding
SC3 GM131986/GM/NIGMS NIH HHS/United States